Bioxcel Therapeutics Stock Technical Analysis
| BTAI Stock | USD 0.34 0.01 2.86% |
As of the 18th of January 2025, BioXcel Therapeutics shows the Standard Deviation of 8.14, mean deviation of 5.54, and Risk Adjusted Performance of (0.03). BioXcel Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
BioXcel Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as BioXcel, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BioXcelBioXcel |
BioXcel Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 2.81 | Buy | 4 | Odds |
Most BioXcel analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand BioXcel stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of BioXcel Therapeutics, talking to its executives and customers, or listening to BioXcel conference calls.
BioXcel Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
BioXcel Therapeutics Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of BioXcel Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
BioXcel Therapeutics Trend Analysis
Use this graph to draw trend lines for BioXcel Therapeutics. You can use it to identify possible trend reversals for BioXcel Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual BioXcel Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.BioXcel Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for BioXcel Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.0061 , which may suggest that BioXcel Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 1.39, which is the sum of squared deviations for the predicted BioXcel Therapeutics price change compared to its average price change.About BioXcel Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of BioXcel Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of BioXcel Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on BioXcel Therapeutics price pattern first instead of the macroeconomic environment surrounding BioXcel Therapeutics. By analyzing BioXcel Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of BioXcel Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to BioXcel Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 (projected) | Payables Turnover | 0.0923 | 0.0831 | 0.0872 | Days Of Inventory On Hand | 576.76 | 663.27 | 630.11 |
BioXcel Therapeutics January 18, 2025 Technical Indicators
Most technical analysis of BioXcel help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BioXcel from various momentum indicators to cycle indicators. When you analyze BioXcel charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | 17.92 | |||
| Mean Deviation | 5.54 | |||
| Coefficient Of Variation | (2,090) | |||
| Standard Deviation | 8.14 | |||
| Variance | 66.25 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (0.59) | |||
| Treynor Ratio | 17.91 | |||
| Maximum Drawdown | 56.57 | |||
| Value At Risk | (11.11) | |||
| Potential Upside | 9.62 | |||
| Skewness | 1.54 | |||
| Kurtosis | 7.72 |
Complementary Tools for BioXcel Stock analysis
When running BioXcel Therapeutics' price analysis, check to measure BioXcel Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioXcel Therapeutics is operating at the current time. Most of BioXcel Therapeutics' value examination focuses on studying past and present price action to predict the probability of BioXcel Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioXcel Therapeutics' price. Additionally, you may evaluate how the addition of BioXcel Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |